PHARMACOKINETICS OF MIFENTIDINE AFTER SINGLE AND MULTIPLE ORAL-ADMINISTRATION TO HEALTHY-VOLUNTEERS

被引:2
作者
IMBIMBO, BP
URSO, R
THIEME, G
STURN, B
UECKERT, B
VIDI, A
LADINSKY, H
DANIOTTI, S
机构
[1] MARIO NEGRI INST PHARMACOL RES,I-20157 MILAN,ITALY
[2] INST KLIN PHARMAKOL,FREIBURG,FED REP GER
关键词
D O I
10.1111/j.1365-2125.1988.tb03399.x
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
引用
收藏
页码:407 / 413
页数:7
相关论文
共 25 条
[1]  
BERMAN M, 1968, USERS MANUAL SAAM
[2]   ACTION OF THE NEW H-2-ANTAGONIST, DA-4577, ON DIFFERENT INVITRO AND INVIVO PREPARATIONS [J].
BERTACCINI, G ;
POLI, E ;
CORUZZI, G .
AGENTS AND ACTIONS, 1984, 14 (3-4) :510-515
[3]   HISTAMINE H2 RECEPTOR ANTAGONISTS MAY MODIFY DOG INTESTINAL MOTILITY INDEPENDENTLY OF THEIR PRIMARY ACTION ON THE H2 RECEPTORS [J].
BERTACCINI, G ;
CORUZZI, G ;
POLI, E .
PHARMACOLOGICAL RESEARCH COMMUNICATIONS, 1985, 17 (03) :241-254
[4]  
COLBURN WA, 1983, J PHARM SCI, V72, P883
[5]  
Davies O.L., 1979, DESIGN ANAL IND EXPT
[6]   CIMETIDINE, RANITIDINE AND MIFENTIDINE IN SPECIFIC GASTRIC AND DUODENAL-ULCER MODELS [J].
DELSOLDATO, P ;
GHIORZI, A ;
CEREDA, E ;
DONETTI, A .
PHARMACOLOGY, 1985, 30 (01) :45-51
[7]  
DIXON WJ, 1983, BMDP STATISTICAL SOF
[8]   (IMIDAZOLYLPHENYL)FORMAMIDINES - A STRUCTURALLY NOVEL CLASS OF POTENT HISTAMINE H-2-RECEPTOR ANTAGONISTS [J].
DONETTI, A ;
CEREDA, E ;
BELLORA, E ;
GALLAZZI, A ;
BAZZANO, C ;
VANONI, P ;
DELSOLDATO, P ;
MICHELETTI, R ;
PAGANI, F ;
GIACHETTI, A .
JOURNAL OF MEDICINAL CHEMISTRY, 1984, 27 (03) :380-386
[9]   PHARMACOKINETICS OF RANITIDINE FOLLOWING ORAL-ADMINISTRATION WITH ASCENDING DOSES AND WITH MULTIPLE-FIXED DOSES [J].
GARG, DC ;
ESHELMAN, FN ;
WEIDLER, DJ .
JOURNAL OF CLINICAL PHARMACOLOGY, 1985, 25 (06) :437-443
[10]   PHARMACOLOGICAL PROFILE OF MIFENTIDINE - A NOVEL H-2-RECEPTOR ANTAGONIST [J].
GIACHETTI, A ;
PAGANI, F ;
MICHELETTI, R ;
BRAMBILLA, A ;
CEREDA, E ;
DONETTI, A .
AGENTS AND ACTIONS, 1985, 16 (3-4) :173-175